Converting-enzyme inhibitors in the treatment of hypertension.
about
Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistReversible impairment of renal function associated with enalapril in a diabetic patient.Aminopeptidase-A. I. CDNA cloning and expression and localization in rat tissues.Management of mild hypertension. Selecting an antihypertensive regimen.Early interventions in the management of acute uncomplicated myocardial infarction.Evolution of drugs that preserve renal function.Localization of a small genomic region associated with elevated ACEOnce vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combinationThe response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.Effect of enalapril on allergen-induced cutaneous hypersensitivity reaction.Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.The effect of captopril on the superior mesenteric artery and portal venous blood flow in normal man.The relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia.Difficulties in achieving arterial hypertension controlSuspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.The rapidly adapting receptors in mammalian airways and their responses to changes in extravascular fluid volume.ACE inhibition versus calcium antagonism in the treatment of mild to moderate hypertension: a multicentre study. Ireland-Netherlands Lisinopril-Nifedipine Study Group.The molecular biology of human renin and its gene.ACE inhibitors in the elderly.Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.Lisinopril therapy associated with acute pancreatitis.The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.Acute renal failure induced by angiotensin converting enzyme inhibitor in a patient with polyarteritis nodosa.Adverse effects of the angiotensin-converting enzyme inhibitors.Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers.Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).Severe angioedema and respiratory distress associated with lisinopril useInvestigation of the biochemical effects of renin inhibition in normal volunteers treated by an ACE inhibitor.Enalapril and bullous eruptions.Taking precautions with ACE inhibitors. A theoretical risk exists in patients with unilateral renal artery stenosis.Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification.Hypertensive cardiovascular disease in African Americans.Effect of pre-operative angiotensin-converting enzyme inhibitors on haemodynamic parameters and vasoconstrictor requirements in patients undergoing off-pump coronary artery bypass surgery.17Beta-oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats.Comparison of enalapril to captopril by 24-hour ambulatory blood pressure monitoring.Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme GeneMeta-Analysis of the Hemodynamic Properties of Antihypertensive Medications
P2860
Q28367875-60AD49AA-706A-4C3E-82AE-5E0F55CF4F58Q28369410-507D94CD-4979-4A53-963B-DC4C85185733Q33179693-955C84B0-DB2D-4B63-8A91-E517B49B6C17Q33558825-0586BA5D-2A45-4A88-9095-D404EC587710Q33608022-664FF6ED-395F-4B80-9007-FAFA2C36CABEQ34024129-4457D01A-859F-4F97-834F-5BD52C06A571Q34146741-5895EBFC-0B89-4AD6-B6A1-D4AB0403E553Q34358617-DC7BC76F-6CCD-43CB-8ABA-835A970FEE6DQ34358706-8B93207E-AD29-40A7-99CC-2B4DE0B95E18Q34358761-6E8B2C2D-63E6-497A-BAE6-633D64450A05Q34403531-70519DA2-9666-4E94-ACD5-0A37430D0EA3Q34404308-6AF80C59-69FE-4FE0-B618-E70143453829Q35591704-F8B68659-0D72-44DE-B096-50CCCBAF864BQ35617775-43C7D18A-B301-4DCB-9746-EAF21DF15192Q36235685-96E8F02B-0E1C-426C-8650-83636FC07961Q36438288-E3779150-7E31-4FA0-BC1F-442E7B0D3BF9Q36683656-D98634B8-DFA1-4347-A73B-2F243AC85646Q36987887-112E56AA-4B28-4AA5-A6EB-6A3F1206E383Q37722708-411B143C-40C1-4703-BD32-D768256F7A24Q38747861-1004162F-F928-41C9-8F11-84E661EED3B4Q39680591-89EB2006-1B08-4B51-A254-CAE66AED7F15Q40237909-8F71D771-5A61-4471-A961-07A54F50D508Q40468415-8533354C-A9D1-4EAD-96E9-030192C80BFEQ41045773-615A73CA-EBB8-4639-A9C1-BA5EED97714FQ41084284-CC144CE4-DED1-4D26-B1A6-AB6C454F971CQ41952564-A1F745BD-D76C-4B04-A3A9-7BA4CE028AE6Q42068724-FAAE5973-C088-4877-867C-6636D5CC64ECQ42178000-CD121517-699E-4888-8ED4-AF194F2542A7Q42265183-76AA8B1D-1081-4C11-A978-1D28A2DECF31Q42618124-2D1D3FD8-D64E-4B56-8792-7413F46529F9Q42757417-163D0C8E-1425-453E-B221-D0304607F30CQ43204936-9999EAEE-82F5-4207-82E2-EF8B3486BEC5Q43224614-BD61493E-DD20-4332-9153-DF2E495245BCQ45944962-78E32ABF-DF5E-4FA7-85CB-10F58E8EE659Q46353950-BAA03701-733D-4196-BDFE-6B3B84D6247BQ46864146-4E8CB442-7538-480E-9E32-995D9766DA33Q51809464-38B211EC-B291-4A12-AB4C-943E6DCA58C2Q53968725-08F4C925-8A8D-4F06-B154-D10B4A73D0C4Q57377961-3F7C7605-81A9-421C-A150-9BCD0690FFB4Q58998629-BC9D0135-6445-4D91-8075-341E014EADC2
P2860
Converting-enzyme inhibitors in the treatment of hypertension.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Converting-enzyme inhibitors in the treatment of hypertension.
@en
Converting-enzyme inhibitors in the treatment of hypertension.
@nl
type
label
Converting-enzyme inhibitors in the treatment of hypertension.
@en
Converting-enzyme inhibitors in the treatment of hypertension.
@nl
prefLabel
Converting-enzyme inhibitors in the treatment of hypertension.
@en
Converting-enzyme inhibitors in the treatment of hypertension.
@nl
P1476
Converting-enzyme inhibitors in the treatment of hypertension.
@en
P2093
Williams GH
P304
P356
10.1056/NEJM198812083192305
P407
P577
1988-12-01T00:00:00Z